A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease

NCT06300320 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Graft Versus Host Disease

Interventions

DRUG: TQ05105 tablets

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.